{
    "root": "2fc14f24-8e1b-0cb8-e063-6394a90a1389",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Irbesartan",
    "value": "20250307",
    "ingredients": [
        {
            "name": "CALCIUM STEARATE",
            "code": "776XM7047L"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE CALCIUM",
            "code": "UTY7PDF93L"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "IRBESARTAN",
            "code": "J0E2756Z7N"
        }
    ],
    "indications": "irbesartan tablet angiotensin ii receptor blocker ( arb ) indicated : • treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) • treatment diabetic nephropathy hypertensive patients type 2 diabetes , elevated serum creatinine , proteinuria . ( 1.2 )",
    "contraindications": "indication dose hypertension ( 2.2 ) 150 300 mg daily diabetic nephropathy ( 2.3 ) 300 mg daily",
    "warningsAndPrecautions": "irbesartan tablets usp , 150 mg white white , capsule shaped , biconvex tablets , debossed '159 ' one side ' h ' side . supplied ndc : 70518-2245-00 packaging : 90 1 bottle plastic store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "irbesartan tablets contraindicated patients hypersensitive component product . co-administrate aliskiren irbesartan tablets patients diabetes .",
    "indications_original": "Irbesartan tablet is an angiotensin II receptor blocker (ARB) indicated for: • Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria. ( 1.2 )",
    "contraindications_original": "Indication Dose Hypertension ( 2.2 ) 150 to 300 mg once daily Diabetic Nephropathy ( 2.3 ) 300 mg once daily",
    "warningsAndPrecautions_original": "Irbesartan Tablets USP, 150 mg are white to off white, capsule shaped, biconvex tablets, debossed with '159' on one side and 'H'  on the other side. They are supplied in\n                  NDC: 70518-2245-00\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  \n                  Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Irbesartan tablets are contraindicated in patients who are hypersensitive to any component of this product. \n    Do not co-administrate aliskiren with irbesartan tablets in patients with diabetes."
}